Update on NF2-associated Schwannomatosis
6th March, 2026, 08:35 - 09:35
Pacific A
This session is for anyone involved in the evaluation and care of patients with NF2 associated schwannomatosis. The session will feature experts discussing the medical, radiosurgical and microsurgical strategies in managing patients with NF2.
Objectives
At the conclusion of this session, attendees will be able to:
- Demonstrate the efficacy of medical management of tumors in NF2 and current clinical trials and results.
- Compare the techniques and results of radiosurgical treatment of meningiomas and schwannomas in NF2.
- Prioritize `which tumor when` decision making in management of NF2-associated schwannomas.
Current Schedule
As a faculty member of this session, you can click on names to email the speaker. Phone numbers are below names
| Speaker | Title | Role | Times |
|---|---|---|---|
| Amir Dehdashti 516-562-3026 |
Moderator | - | |
| Konstantina Stankovic 617.573.3972 |
Moderator | - | |
| Konstantina Stankovic 617.573.3972 |
Introduction | Introduction | 8:35 am - 8:37 am |
| P. Leia Nghiemphu |
Update on Medical Therapy and Clinical Trials | Speaker | 8:37 am - 8:47 am |
| Jason Sheehan (434) 924-8129 |
Role of Radiosurgery | Speaker | 8:47 am - 8:57 am |
| J. Thomas Roland, Jr. (212) 263-5565 |
Surgical Management of NF2 - Which Tumor, When? | Speaker | 8:57 am - 9:07 am |
| Amir Dehdashti 516-562-3026 |
Case Presentations & Discussion: Malignant Transformation and Radiation | Speaker | 9:07 am - 9:30 am |
| Konstantina Stankovic 617.573.3972 |
Case Presentations & Discussion: Malignant Transformation and Radiation | Speaker | 9:07 am - 9:30 am |
| |
Q&A | 9:30 am - 9:35 am |